Renovaro Biosciences
Price & Volume
Stats
See moreOpen | $0.35 |
Previous Close | $0.35 |
Day Range | $0.30-$0.35 |
52W Range | $0.30-$2.10 |
Market Cap | $58.4M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.95 |
News
See moreYahoo Finance • 9 days ago
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
Yahoo Finance • 22 days ago
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
Yahoo Finance • 27 days ago
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
Yahoo Finance • 2 months ago
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
About
CEO | Mr. David H. Weinstein |
Address | 2080 Century Park East, Los Angeles, CA, United States, 90067 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
